At the time of writing, Nutex Health Inc [NUTX] stock is trading at $142.34, up 26.87%. An important factor to consider is whether the stock is rising or falling in short-term value. The NUTX shares have gain 30.82% over the last week, with a monthly amount glided 24.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Nutex Health Inc [NASDAQ: NUTX] stock has seen the most recent analyst activity on November 12, 2024, when Maxim Group reiterated its Buy rating and also boosted its price target to $50 from $45. Previously, Maxim Group started tracking the stock with Buy rating on September 18, 2024, and set its price target to $45. On February 22, 2023, Northland Capital initiated with a Outperform rating and assigned a price target of $3 on the stock.
For the past year, the stock price of Nutex Health Inc fluctuated between $28.12 and $184.27. Currently, Wall Street analysts expect the stock to reach $205 within the next 12 months. Nutex Health Inc [NASDAQ: NUTX] shares were valued at $142.34 at the most recent close of the market. An investor can expect a potential return of 44.02% based on the average NUTX price forecast.
Analyzing the NUTX fundamentals
According to Nutex Health Inc [NASDAQ:NUTX], the company’s sales were 981.20M for trailing twelve months, which represents an 239.87% jump. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.41 and Total Capital is 0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 125.56 points at the first support level, and at 108.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 158.56, and for the 2nd resistance point, it is at 174.78.
Ratios To Look Out For
It is important to note that Nutex Health Inc [NASDAQ:NUTX] has a current ratio of 3.20. On the other hand, the Quick Ratio is 3.18, and the Cash Ratio is 0.9. Considering the valuation of this stock, the price to sales ratio is 1.03, the price to book ratio is 3.10 and price to earnings (TTM) ratio is 7.38.
Transactions by insiders
Recent insider trading involved Bates Jon Christian, Chief Financial Officer, that happened on Apr 08 ’25 when 1000.0 shares were purchased.
